Clinical Trials Logo

Clinical Trial Summary

Summary

Chronic heart failure continues to be one of the highest economic burdens in the United States, heavily influenced by frequent readmissions to the hospital. This study will examine whether patients 65 years and older, who have NYHA class II and III heart failure, will improve their symptoms after participating in a comprehensive 12-week lifestyle change program. The investigators will recruit potential subjects primarily from the Scripps Clinic heart failure clinic at the Torrey Pines campus. Qualifying subjects will be randomized to medical treatment as usual or the lifestyle program. The investigators will enroll 17 subjects into each group which will provide 80% power and an alpha of 0.05.

The lifestyle change program consists of classes conducted three times a week for 12 weeks at the Scripps Center for Integrative Medicine. Each day participants will spend about four to five hours in a variety of classes such as monitored exercise, group support, mindful-yoga and meditation, vegetarian cooking classes, music-centered wellness, mind-body lectures, and resiliency training.

The primary outcomes will focus on determining functional status and physical agility using the 6-minute walk test, handgrip strength, and NYHA class categories. In addition, the investigators will capture subjective physical status with a self-reported questionnaire. Cognitive assessment will be performed using the Montreal Cognitive Assessment tool. To capture the subject's overall self-reported improvement the investigators will use a quality of life and a depression questionnaire. Secondary endpoints include hospital admission rates and all-cause mortality.


Clinical Trial Description

The investigators Research Question and Hypothesis is as follows:

Comprehensive, evidence-based lifestyle and psychosocial interventions over a 12-week period (Lifestyles Change Program) can improve various objectives (6-minute walk distance, Left Ventricular Ejection Fraction (LVEF), New York Heart Association Class, grip strength, and cognitive function) as well as subjective (Quality of life, depression and functional screening) measures in patients with chronic heart failure. Secondary endpoints would include data such as hospital admission rates and all-cause mortality.

Background/ Gaps in Knowledge Chronic heart failure continues to be one of the highest economic burdens in the United States, heavily influenced by frequent readmissions. As a measure of performance quality, the Center of Medicare and Medicaid Services (CMS) began publically reporting hospital risk-standardized 30-day all-cause readmission rates, among fee-for-service beneficiaries discharged after hospitalization for heart failure from all the US acute care hospitals (1). Previous reported averages for hospital readmission in patients with chronic heart failure averages 25% to 30%, with some studies showing a readmission rate of up to 45% at 6 months.

There has been significant research examining various methods to reduce hospital admissions and improve functional capacity for patients with heart failure. Aside from published data on patient factors associated with readmission (age, sex, race, education, diabetes, renal disease, history of stroke, cognitive impairment, New York Heart Association (NYHA) class level, and serum markers [blood urea nitrogen, creatinine, C-reactive protein], etc), there have been many prospective studies evaluating readmission rates in CHF using interventions including: specialized multi-disciplinary teams (CHF nursing staff, pharmacists, physicians, etc), telephonic home monitoring, implantable device monitoring, various exercise programs (intermittent vs. continuous), meditation and spirituality, and early hospital follow-up.

Attempts at creating valid statistical models to predict patients at the highest risk for readmission used heterogeneous approaches and found substantial inconsistencies regarding which patient characteristics were predictive. From a policy perspective, as of 2009, a validated risk-standardized model to accurately profile hospitals using readmission rates is unavailable in the published English-language literature to date (3). Essentially, the identification of patients at high risk for heart failure readmission remains difficult with no validated objective assessment. Therefore, the strategy to reduce readmissions of heart failure patients is evolving to become a more personalized, patient-centered approach based on specific needs of each patient. For example, studies evaluating patient vs physician and healthcare staff perceptions for the causes of heart failure readmissions (using standardized questionnaires), shows discrepancy in the physician's opinion vs the patient's opinion about what factors influenced the readmission.

In essence, various aspects of the LCP have been evaluated in controlled clinical trials, but an overall, comprehensive study evaluating multiple components as included in the LCP has (to the investigators knowledge) not been done. Previous randomized controlled trials have shown benefit (6-minute walk, NYHA class, etc) using cardiac rehabilitation in patients with CHF (12). Yoga has been shown to improve exercise tolerance and positively affected levels of inflammatory markers in patients with CHF, with trends towards improvements in QoL (11). Education by a dietitian in patients with CHF has also been shown to result in a significant decrease in sodium intake compared with patients who simply receive written instructions (9). Studies have also evaluated spiritual well-being and depression in patients with heart failure, and have shown that greater spiritual well-being, particularly meaning/ peace was strongly associated with less depression (6). Interestingly, Tai Chi has been used in complimentary medicine for many years in patients with cardiovascular disease. Recently, a randomized study in 2011 showed that Tai Chi exercise improves quality of life, mood, and exercise self-efficacy in patients with CHF (5).

The investigators goal with the currently described study is to use a comprehensive, evidence-based Lifestyle Change Program (LCP) that incorporates all of the above individual components in a single program, individualized to each patient's physical abilities. Moreover, the investigators hypothesis is that such an intervention with chronic heart failure patients will improve Quality of Life, objective cardiometabolic markers, and reduce hospital admissions.. ;


Study Design

Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT02303275
Study type Interventional
Source Scripps Center for Integrative Medicine
Contact Christopher Suhar, MD
Phone 858-554-3330
Email suhar.christopher@scrippshealth.org
Status Recruiting
Phase N/A
Start date May 2013
Completion date May 2016

See also
  Status Clinical Trial Phase
Recruiting NCT05654272 - Development of CIRC Technologies
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy